Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

UCB Transaction in Own Shares 2020

Mar 11, 2020

4017_dirs_2020-03-11_c10401e0-8fa3-4f08-a390-5a469108017c.pdf

Transaction in Own Shares

Open in viewer

Opens in your device viewer

Disposal of own shares

Brussels (Belgium), 11 March 2020 – 20:00 (CET) – regulated information

In application of article 8:6 of the Royal Decree executing the new Belgian Code of Companies and Associations, UCB SA/NV announces that following exercises of stock options by its employees, it has disposed of UCB shares OTC in view of deliveries of shares to the relevant employees, within the framework of the Long Term Incentive Program of the UCB Group, as follows:

Date of transaction Time LTI Plan Number of disposed UCB
shares
Price
02 March 2020 17:15:39 Stock Option Plan 2010 100 € 31.62
03 March 2020 09:59:24 Stock Option Plan 2012 600 € 32.36
03 March 2020 10:14:39 Stock Option Plan 2010 200 € 31.62
03 March 2020 10:30:20 Stock Option Plan 2012 900 € 32.36
03 March 2020 10:30:50 Stock Option Plan 2011 1,000 € 26.72
03 March 2020 10:33:12 Stock Option Plan 2014 1,036 € 58.12
03 March 2020 10:36:35 Stock Option Plan 2015 596 € 67.35
03 March 2020 10:37:46 Stock Option Plan 2011 4,000 € 26.72
03 March 2020 11:41:50 Stock Option Plan 2016 200 € 67.24
03 March 2020 11:42:35 Stock Option Plan 2012 2,500 € 32.36
03 March 2020 11:48:46 Stock Option Plan 2012 2,500 € 32.36
03 March 2020 11:50:03 Stock Option Plan 2013 2,740 € 48.69
03 March 2020 12:06:00 Stock Option Plan 2012 2,500 € 32.36
03 March 2020 13:02:10 Stock Option Plan 2014 2,877 € 58.12
03 March 2020 14:26:30 Stock Option Plan 2011 200 € 26.72
03 March 2020 14:37:26 Stock Option Plan 2012 500 € 32.36
03 March 2020 14:51:59 Stock Option Plan 2013 4,000 € 48.69
03 March 2020 14:55:52 Stock Option Plan 2014 2,000 € 58.12
03 March 2020 15:23:25 Stock Option Plan 2010 1,000 € 31.62
03 March 2020 15:27:39 Stock Option Plan 2011 500 € 26.72
03 March 2020 15:31:01 Stock Option Plan 2010 1,500 € 31.62
03 March 2020 16:03:39 Stock Option Plan 2013 1,000 € 48.69
03 March 2020 16:04:22 Stock Option Plan 2016 100 € 67.24
03 March 2020 16:08:39 Stock Option Plan 2010 1,000 € 31.62
04 March 2020 13:33:53 Stock Option Plan 2011 200 € 26.72
04 March 2020 14:10:07 Stock Option Plan 2010 2,500 € 31.62
04 March 2020 17:35:17 Stock Option Plan 2013 300 € 48.69
05 March 2020 09:00:29 Stock Option Plan 2014 1,000 € 58.12
05 March 2020 09:00:29 Stock Option Plan 2015 957 € 67.35
05 March 2020 09:00:48 Stock Option Plan 2013 500 € 48.69
05 March 2020 09:01:08 Stock Option Plan 2016 1,398 € 67.24
05 March 2020 09:08:33 Stock Option Plan 2016 100 € 67.24
05 March 2020 09:15:14 Stock Option Plan 2012 750 € 32.36
05 March 2020 09:16:00 Stock Option Plan 2011 500 € 26.72
05 March 2020 10:36:08 Stock Option Plan 2011 300 € 26.72
05 March 2020 10:48:59 Stock Option Plan 2012 800 € 32.36
05 March 2020 17:18:20 Stock Option Plan 2010 700 € 31.62

This press release is available on UCB SA/NV's website via the following link.

Investor Relations

Antje Witte, Investor Relations, UCB T +32 2 559 94 14, [email protected]

Isabelle Ghellynck, Investor Relations, UCB T +32 2 559 95 88, [email protected]

About UCB

UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With 7 500 people in approximately 40 countries, the company generated revenue of € 4.9 billion in 2019. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twitter: @UCB_news